MedTrace Logo

Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder

NCT02431091 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2022-03-31

No results posted yet for this study

Summary

The purpose of this study is to determine the sensitivity and specificity of the use of optical coherence tomography to detect HIV-associated neurocognitive disorder compared to MRI and usual cognitive screening tools.

Conditions

  • AIDS-Related Dementia Complex

Interventions

OTHER

Optical Coherence Tomography

Optical Coherence Tomography provides a non invasive evaluation of the thickness of different layers of the retina

Sponsors & Collaborators

  • Fonds iris-Recherche, Fondation Roi Baudouin, Belgium

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire Saint Pierre

    lead OTHER

Principal Investigators

  • Stéphane Dewit, PhD · CHU St Pierre, Service des Maladies Infectieuses

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02431091 on ClinicalTrials.gov